1. Home
  2. NRXP vs GWH Comparison

NRXP vs GWH Comparison

Compare NRXP & GWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • GWH
  • Stock Information
  • Founded
  • NRXP 2015
  • GWH 2011
  • Country
  • NRXP United States
  • GWH United States
  • Employees
  • NRXP N/A
  • GWH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • GWH Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • GWH Miscellaneous
  • Exchange
  • NRXP Nasdaq
  • GWH Nasdaq
  • Market Cap
  • NRXP 73.7M
  • GWH 87.1M
  • IPO Year
  • NRXP N/A
  • GWH N/A
  • Fundamental
  • Price
  • NRXP $2.14
  • GWH $2.52
  • Analyst Decision
  • NRXP Strong Buy
  • GWH Hold
  • Analyst Count
  • NRXP 5
  • GWH 3
  • Target Price
  • NRXP $31.60
  • GWH $2.67
  • AVG Volume (30 Days)
  • NRXP 480.7K
  • GWH 963.0K
  • Earning Date
  • NRXP 11-17-2025
  • GWH 11-13-2025
  • Dividend Yield
  • NRXP N/A
  • GWH N/A
  • EPS Growth
  • NRXP N/A
  • GWH N/A
  • EPS
  • NRXP N/A
  • GWH N/A
  • Revenue
  • NRXP $242,000.00
  • GWH $6,021,000.00
  • Revenue This Year
  • NRXP N/A
  • GWH $131.04
  • Revenue Next Year
  • NRXP $395.09
  • GWH $76.74
  • P/E Ratio
  • NRXP N/A
  • GWH N/A
  • Revenue Growth
  • NRXP N/A
  • GWH N/A
  • 52 Week Low
  • NRXP $1.13
  • GWH $0.76
  • 52 Week High
  • NRXP $6.01
  • GWH $13.87
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 31.88
  • GWH 38.46
  • Support Level
  • NRXP $2.04
  • GWH $2.40
  • Resistance Level
  • NRXP $2.81
  • GWH $4.67
  • Average True Range (ATR)
  • NRXP 0.22
  • GWH 0.47
  • MACD
  • NRXP -0.06
  • GWH -0.29
  • Stochastic Oscillator
  • NRXP 7.41
  • GWH 4.68

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

Share on Social Networks: